
PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation, is a global biopharmaceutical innovator specializing in the development and delivery of new biologics for hematology, oncology, and immunology. With a focus on rare diseases and orphan drugs, the company leverages deep expertise and proven scientific principles to advance drug development. Founded in 2003, PharmaEssentia has expanded its global presence across the U.S., Japan, China, and Korea.
PharmaEssentia Innovation Research Center (PIRC) is seeking a highly motivated and experienced Senior/Principal Scientist to join their Translational Sciences team and contribute to the development of first-in-class and best-in-class biotherapeutics. The role involves designing and executing translational studies, analyzing biomarker data, and contributing to drug development strategy, regulatory interactions, and mentorship of junior scientists. PIRC focuses on myeloid proliferative neoplasms, and its new R&D center aims to expand expertise in related therapeutic areas.
PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation, is a global biopharmaceutical innovator specializing in the development and delivery of new biologics for hematology, oncology, and immunology. With a focus on rare diseases and orphan drugs, the company leverages deep expertise and proven scientific principles to advance drug development. Founded in 2003, PharmaEssentia has expanded its global presence across the U.S., Japan, China, and Korea.